| 000 | 01613 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513130826.0 | ||
| 264 | 0 | _c19971218 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a8756-0437 | ||
| 024 | 7 |
_a10.1002/(sici)1098-2388(199711/12)13:6<438::aid-ssu8>3.0.co;2-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRagde, H | |
| 245 | 0 | 0 |
_aBrachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up. _h[electronic resource] |
| 260 |
_bSeminars in surgical oncology _c |
||
| 300 |
_a438-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aActuarial Analysis |
| 650 | 0 | 4 |
_aAdenocarcinoma _xmortality |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMorbidity |
| 650 | 0 | 4 |
_aPalladium _xtherapeutic use |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 |
_aRadioisotopes _xtherapeutic use |
| 650 | 0 | 4 | _aRadiotherapy, High-Energy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBlasko, J C | |
| 700 | 1 | _aGrimm, P D | |
| 700 | 1 | _aKenny, G M | |
| 700 | 1 | _aSylvester, J | |
| 700 | 1 | _aHoak, D C | |
| 700 | 1 | _aCavanagh, W | |
| 700 | 1 | _aLandin, K | |
| 773 | 0 |
_tSeminars in surgical oncology _gvol. 13 _gno. 6 _gp. 438-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1098-2388(199711/12)13:6<438::aid-ssu8>3.0.co;2-b _zAvailable from publisher's website |
| 999 |
_c9328839 _d9328839 |
||